Finance

Beta
Lists
2871:TYO
Nichirei Corp
Â¥1,924.50
+0.89%
(+17.00) 1D
Jun 4, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2871...
Open
Â¥1,916
High
Â¥1,954
Low
Â¥1,902
Mkt. cap
494.57B
Avg. vol.
1.28M
Volume
1.66M
Dividend
2.44%
Quarterly dividend
Â¥12
Ex-dividend date
Mar 30, 2026
P/E ratio
17.65
52-wk high
Â¥2,157
52-wk low
Â¥1,628
EPS
Â¥109
Shares outstanding
133.27M
No. of employees
17K
Open
Â¥1,916
High
Â¥1,954
Low
Â¥1,902
Mkt. cap
494.57B
Avg. vol.
1.28M
Volume
1.66M
Dividend
2.44%
Quarterly dividend
Â¥12
Ex-dividend date
Mar 30, 2026
P/E ratio
17.65
52-wk high
Â¥2,157
52-wk low
Â¥1,628
EPS
Â¥109
Shares outstanding
133.27M
No. of employees
17K
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to 2871 in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for 2871 in the last 3 months.
Highest
Current ¥1,924.50
Â¥2,350.00 (+22.11%)
Average
Â¥2,225.32 (+15.63%)
Lowest
Â¥2,100.00 (+9.12%)
News stories
From sources across the web
Profile
Nichirei Corporation is one of Japan's top producers of frozen foods and a leader in cold storage warehousing, headquartered in Tokyo. Operating through around 80 subsidiaries and affiliates worldwide, its businesses include processed food; logistics; marine products; meat and poultry; real estate; and biosciences. The company's bioscience work includes antibody development and manufacturing, immunology products, and natural materials processing. Wikipedia
About Nichirei Corp
CEO-
Employees16.6K
FoundedDec 24, 1942
HeadquartersChuo City, Tokyo, Japan
SectorFood
Websitenichirei.co.jp
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
178.48B / 170.00B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
170.76B
176.94B
189.96B
178.48B
Cost of goods sold
139.11B
144.83B
155.45B
147.53B
Cost of revenue
139.11B
144.83B
155.45B
147.53B
Research and development expenses
504.00M
503.00M
483.00M
483.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.46B
21.99B
21.80B
22.00B
Operating expense
22.96B
22.50B
22.28B
22.48B
Total operating expenses
162.07B
167.33B
177.74B
170.01B
Operating income
8.70B
9.61B
12.22B
8.47B
Other non operating income
3.00M
87.00M
-277.00M
337.00M
EBT including unusual items
8.76B
13.09B
11.83B
7.84B
EBT excluding unusual items
9.32B
9.45B
12.58B
8.80B
Income tax expense
2.43B
4.10B
3.88B
2.28B
Effective tax rate
27.72%
31.29%
32.79%
29.09%
Other operating expenses
-
-
-
-
Net income
5.65B
8.50B
7.71B
5.47B
Net profit margin
3.31%
4.80%
4.06%
3.07%
Earnings per share
-
-
-
-
Interest and investment income
757.00M
292.00M
503.00M
252.00M
Interest expense
-326.00M
-335.00M
-347.00M
-365.00M
Net interest expenses
431.00M
-43.00M
156.00M
-113.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
14.97B
-
13.99B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer